HEMIGARD™ Adhesive Retention Suture Device Used to Prevent Surgical Wound Dehiscence

SUTUREGARD® Medical, Inc. Blog

 
07Jul

Press Release - SUTUREGARD® Medical, Inc’s HEMIGARD™ Adhesive Retention Suture Device Used to Prevent Surgical Wound Dehiscence

Dr. Windy Cole, DPM and Alex McKanna, DPM have released The Use of a Novel Suture Retention Device to Prevent Surgical Wound Dehiscence (SWD) case report, where the HEMIGARD™ ARS device was used to augment skin closure and prevent dehiscence. 

“The HEMIGARD™ is a simple, inexpensive device that can easily be added to standard of care skin closure techniques to prevent SWD and improve patient outcomes.” - Dr. Cole and Dr. McKanna

Surgical wound dehiscence (SWD) is defined as the separation of the margins of a closed surgical incision that has been made in the skin, with or without exposure or protrusion of underlying tissue, organs, or implants. The re-approximation of skin incisions after invasive surgical interventions can be challenging and SWD is a common complication. 

According to the case study, the best course of treatment for SWD is prevention, and the use of the HEMIGARD™ device appears successful, “All surgical incisions were noted to be completely healed by 4 weeks post-op and the HEMIGARD devices were removed.”

In this case report, the addition of the HEMIGARD™ constructs to the post-surgical skin closure on the left foot allowed for the transfer of tension away from the vulnerable incision site during episodes of postop edema, thus preventing incision dehiscence.

The HEMIGARD™ has shown favorable results in Mohs surgery, and this case report suggests that there are similar advantages seen when the device is used in complex skin closures following surgical reconstruction in the foot and ankle. The authors believe that the HEMIGARD is a simple, inexpensive device that can easily be added to standard of care skin closure techniques to prevent SWD and improve patient outcomes.

The SUTUREGARD® ISR Retention Suture Device and the HEMIGARD™ Adhesive Retention Suture Device allow surgeons to initiate approximation of high-tension surgical wounds with suture without damaging the skin. The devices do this by dispersing the pressure of the suture away from the wound edges.

Based in Portland, Oregon, SUTUREGARD® Medical, Inc is a private company offering novel medical devices for surgeons to repair challenging surgical defects more simply. SUTUREGARD® medical devices are intended to provide minimal wound trauma and reduce the healing period after surgery, providing better results for patients.

Related

Low Tension Healing: The Future of Scar Surgery

How many times have you done an elliptical excision, and the postoperative scar result is widened at...

Read More >

You have a skin cancer for which your doctor recommends Mohs surgery. What is Mohs Surgery?

First, let’s back up. Tissue is sent for pathology to answer one of two questions: “what is it?” ...

Read More >

Press Release - SUTUREGARD® Presenting at the American Society for Mohs Surgery

SUTUREGARD® Medical will be presenting at the American Society for Mohs Surgery (ASMS) Closure Cours...

Read More >

Press Release - Patient Self-Removal of HEMIGARD During COVID Now Published

JAAD Case Reports recently published, “Use of a novel adhesive suture retention wound closure devic...

Read More >

Bill Lear, MD, Discusses Development of HEMIGARD ARS

Bill Lear, MD, Mohs surgeon now but 5-year emergency physician previously, talks with Dr. Mark Plast...

Read More >

Press Release - Operation Smile

The official collaboration between Operation Smile & SUTUREGARD® Medical Inc. Operation Smile is the...

Read More >

Relax & Close, More Wounds, More Simply.

Making wound closure easier for surgeons and better for patients.

Contact Us